Dr Jeremy Rees

Dr Jeremy ReesTel: 020 3448 3015
Fax: 020 3448 8994
Email: jeremy.rees2@nhs.net

Location:
University College Hospital; National Hospital for Neurology and Neurosurgery

Specialities:
Brain Tumour Service (Neuro-Oncology), Neurology and neurosurgery

Professional background

Dr Jeremy Rees qualified in 1988 from University College and Middlesex Medical School with distinctions in Medicine, Surgery and Therapeutics. After postgraduate training, including a spell at Memorial Sloan Kettering Hospital, New York, in 1999 he was appointed as Honorary Senior lecturer in Neuro-oncology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. He specializes in the management of low-grade brain tumours and neurological complications of cancer.

He has been the Clinical Lead for the Brain Tumour Unit at NHNN and the Pathway Director for Brain Cancer at London Cancer, an Integrated Cancer System. He has carried out extensive research into multimodality imaging of Low Grade Gliomas and has edited a textbook on Neuro-oncology, and written numerous peer-reviewed research papers and chapters on Brain Tumours.

Research interests

  • Low grade gliomas
  • Imaging of Brain Tumours

Publications

  1. Aggarwal A, Herz N, Campbell P, Arkush L, Short S, Rees J. Diagnostic delay and survival in high grade gliomas – evidence of the “waiting time paradox”? Br J Neurosurg 2015; Mar 4:1-4.
  2. Rees J. Temozolomide in low-grade gliomas: living longer and better. J Neurol Neurosurg Psychiatry 2015;86: 359-60
  3. Rees J. Paraneoplastic neurological disorders. J Neurol Neurosurg Psychiatry 2014; 85: e3
  4. Gratwicke JP, Alli A, Rollin M, Vaz F, Rees J, Vincent A, Edwards M. Paraneoplastic cerebellar syndrome and sensory ganglionopathy with papillary thyroid carcinoma. J Neurol Sci 2014; 341: 183-4
  5. Bradley D, Rees J. Updates in the management of high-grade glioma. J Neurol 2014;261:651-654
  6. Bradley D, Rees J Brain tumour mimics and chameleons. Pract Neurol. 2013;13:359-71
  7. Bozzali M, MacPherson SE, Cercignani M, Crum WR, Shallice T, Rees JH.White matter integrity assessed by diffusion tensor tractography in a patient with a large tumor mass but minimal clinical and neuropsychological deficits. Funct Neurol. 2012;27:239-46.
  8. Rees J. Midbrain encephalitis associated with neoplasia: commentary. Practical Neurology 2013;13:181-2.
  9. Neurol. 2013 Jun;13(3):181-2.
  10. Rusbridge SL, Walmsley NC, Griffiths SB, Wilford PA, Rees JH. Predicting outcomes of vocational rehabilitation in patients with brain tumours. Psychooncology. 2013;22:1907-11
  11. Sanghera P, Rampling R, Haylock B, Jefferies S, McBain C, Rees JH, Soh C, Whittle IR. The concepts, diagnosis and management of early imaging changes after therapy for glioblastomas. Clin Oncol (R Coll Radiol). 2012 ;24:216-27
  12. Rees JH. Diagnosis and Treatment in Neuro-oncology: an oncological perspective. Br J Radiol 2011; 84: S82-S89
  13. Soffietti R, Baumert BG, Bello L et al. Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 2010; 17: 1124-33
  14. Tozer DJ, Rees JH, Benton CE, et al. Quantitative magnetisation transfer imaging in glioma: preliminary results. NMR Biomed 2011; 24:492-8
  15. Brasil Caseiras G, Ciccarelli O, Altmann DR, et al. Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 2009; 253: 505-12
  16. Waldman AD, Jackson A, Price SJ, et al. National Cancer Research Institute Brain Tumour Imaging Subgroup. Quantitative imaging biomarkers in neuro-oncology. Nat Rev Clin Oncol 2009; 6: 445-54.
  17. Rees J, Watt H, Jäger HR, et al Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol 2009; 72: 54-64
  18. Danchaivijitr N, Waldman AD, Tozer DJ, et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 2008; 247: 170-8

GMC/GDC number: 3196139